Roche (China)

本机构学者在这里署名、按本站篇数

合作机构同一篇文章里的其他机构

1. Kyushu University日本1
2. National Cancer Center Hospital East日本1
3. Wakayama Medical University日本1
4. The Cancer Institute Hospital日本1
5. Chugai Pharmaceutical Co., Ltd. (Japan)日本1
6. Kanagawa Cancer Center1
7. Genentech1
8. National Hospital Organization Kyushu Cancer Center日本1

按月发文

逐年被引

最新文献

1. 1
   Erlotinib Plus Bevacizumab Phase ll Study in Patients with Advanced Non-small-Cell Lung Cancer (JO25567): Updated Safety ResultsDrug Safety201758

高被引文献

1. 1
   Erlotinib Plus Bevacizumab Phase ll Study in Patients with Advanced Non-small-Cell Lung Cancer (JO25567): Updated Safety ResultsDrug Safety201758

主要发表期刊